Covered recipient · General Payments record
LOGAN RADEMACHER
General Payments · PY2022–2024
$712.52
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $463.17 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ACADIA Pharmaceuticals Inc | $196.12 | 3 |
| Alexion Pharmaceuticals, Inc. | $138.54 | 2 |
| Neurelis, Inc. | $38.40 | 1 |
| UCB, Inc. | $37.15 | 1 |
| EISAI INC. | $20.46 | 1 |
| SK Life Science, Inc. | $19.28 | 1 |
| Genentech USA, Inc. | $13.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $74.85 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147988373 | CMS |
| ACADIA Pharmaceuticals Inc | $35.24 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147988375 | CMS |
| ACADIA Pharmaceuticals Inc | $86.03 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147988377 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.86 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110508820 | CMS |
| Alexion Pharmaceuticals, Inc. | $119.68 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110507594 | CMS |
| Eisai Inc. | $20.46 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110760914 | CMS |
| Genentech USA, Inc. | $13.22 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133055528 | CMS |
| Neurelis, Inc. | $38.40 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145651552 | CMS |
| SK Life Science, Inc. | $19.28 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154128110 | CMS |
| UCB, Inc. | $37.15 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143373584 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.